These novel medications , including Semaglutide , Tirzepatide , and Zaxig , represent a significant advancement in addressing type 2 hyperglycemia and supporting weight management. They work by mimicking the body’s natural incretin GLP-1 , helping to regulate blood glucose and lower appetite . Each drug has slightly different qualities and can be